-
公开(公告)号:US20050137188A1
公开(公告)日:2005-06-23
申请号:US10823995
申请日:2004-04-14
IPC分类号: A61K31/437 , A61K31/4375 , A61K31/496 , A61K31/5377 , A61P9/00 , A61P35/00 , A61P43/00 , C07D471/04 , C07D495/04 , C07D519/00 , A61K31/551 , A61K31/4439 , A61K31/4545 , A61K31/541 , C07D413/14 , C07D417/14
CPC分类号: C07D471/04 , C07D495/04
摘要: Organic compounds having the structural formula I are provided where the variables have the values described herein and R1 and R2 join together to form a 6 membered substituted or unsubstituted ring including at least one O, N, or S atom, and Z is an O, S, NH or NR group. Pharmaceutical formulations include the organic compound or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier.
摘要翻译: 提供具有结构式I的有机化合物,其中变量具有本文所述的值,并且R 1和R 2连接在一起以形成6元取代或未取代的环,其包括在 至少一个O,N或S原子,Z是O,S,NH或NR基团。 药物制剂包括有机化合物或其药学上可接受的盐和药学上可接受的载体。